NCT03072485View on ClinicalTrials.gov

Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

February 22, 2019

Study Completion Date

February 22, 2019

Conditions
Aging
Interventions
DRUG

Sirolimus

Topical sirolimus applied to the skin

DRUG

Metformin

Topical metformin applied to the skin

DRUG

Diclofenac

Topical diclofenac applied to the skin

Trial Locations (1)

94603

Stanford Dermatology, Redwood City

All Listed Sponsors
lead

Anne Chang

OTHER

NCT03072485 - Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers | Biotech Hunter | Biotech Hunter